Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel and Encequidar in Patients with Metastatic Breast Cancer

Ads

You May Also Like

Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update

Completes Sale of Hyperimmune Commercial Business for up to $74.5 Million Forms Strategic Bispecific ...

Orion’s and Bayer’s darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial

Orion Corporation                                                                            Press ReleaseCommunications                                                                              14 February 2019 at 11.45 p.m. EET Orion's and ...

Robin Hood submits declaration in attorneys general lawsuit against forced family separation policies

Leading poverty-fighting organization cites “irreparable social and emotional trauma” and “lifelong consequences” for hundreds ...